Taxonomic classification revisited.
Exploratory data analysis.
Co-occurrence and mutual exclusion.
Using meta-cohort analysis, GeneCreek is capable of predicting synergy or competitive exclusion between species. At present, we have over 6,000 cur|sor analyzed clinical gut samples for these predictions. No patient metadata is required for this analysis. One of the uses is the discovery of beneficial bacteria, typically GRAS/QPS* species, suitable for use in probiotics compositions, with antagonistic activity against particular pathogens or pathobionts - commensal bacteria with negative influence on health in a particular situation.
*generally recognized as safe (FDA denomination) or qualified presumption of safety (EFSA denomination)